Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bug

Showing results (201-210 of 319) with videos related to

Pageof 32
Sort By:
International Journal of Cardiology|October 27, 2018
CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mappingJasmin D Haslbauer, Sarah Lindner, Silvia Valbuena-Lopez, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantationSarah Weber, Sebastian Scheich, Aaron Magh, et al.
Bone Marrow Transplantation|December 9, 2020
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyKlaus Hirschbühl, Myriam Labopin, Mohamed Houhou, et al.
Blood|April 9, 2005
Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Michael Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromesFelicitas Thol, Inna Friesen, Frederik Damm, et al.
Leukemia|May 8, 2013
SETBP1 mutation analysis in 944 patients with MDS and AMLF Thol, K J Suchanek, C Koenecke, et al.
Haematologica|November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationMartin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.
Blood|March 20, 2013
β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axisThomas Oellerich, Mark F Oellerich, Michael Engelke, et al.
Leukemia Research|August 4, 2018
The IPSS-R has prognostic impact in untreated patients with MDS del(5q)J Kaivers, M Lauseker, B Hildebrandt, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Pageof 32

Showing results (201-210 of 319) with videos related to

Sort By:
Pageof 32
International Journal of Cardiology|October 27, 2018
CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mappingJasmin D Haslbauer, Sarah Lindner, Silvia Valbuena-Lopez, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantationSarah Weber, Sebastian Scheich, Aaron Magh, et al.
Bone Marrow Transplantation|December 9, 2020
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyKlaus Hirschbühl, Myriam Labopin, Mohamed Houhou, et al.
Blood|April 9, 2005
Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Michael Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromesFelicitas Thol, Inna Friesen, Frederik Damm, et al.
Leukemia|May 8, 2013
SETBP1 mutation analysis in 944 patients with MDS and AMLF Thol, K J Suchanek, C Koenecke, et al.
Haematologica|November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationMartin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.
Blood|March 20, 2013
β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axisThomas Oellerich, Mark F Oellerich, Michael Engelke, et al.
Leukemia Research|August 4, 2018
The IPSS-R has prognostic impact in untreated patients with MDS del(5q)J Kaivers, M Lauseker, B Hildebrandt, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Pageof 32